Edition:
United Kingdom

Altimmune Inc (ALT.OQ)

ALT.OQ on NASDAQ Stock Exchange Global Market

2.91USD
18 Jan 2019
Change (% chg)

$-0.19 (-6.13%)
Prev Close
$3.10
Open
$3.08
Day's High
$3.08
Day's Low
$2.88
Volume
50,762
Avg. Vol
197,415
52-wk High
$58.50
52-wk Low
$1.70

Chart for

About

Altimmune, Inc., formerly Pharmathene, Inc., is a clinical-stage immunotherapeutic company. The Company focuses in development of medical counter measures against biological and chemical threats. The Company is involved in development of two next generation anthrax vaccines. It has two proprietary platform technologies,... (more)

Overall

Beta: 2.96
Market Cap(Mil.): $35.38
Shares Outstanding(Mil.): 15.59
Dividend: 29.10
Yield (%): --

Financials

  ALT.OQ Industry Sector
P/E (TTM): 0.08 69.71 33.71
EPS (TTM): 27.25 -- --
ROI: 326.16 8.99 14.48
ROE: 357.56 10.13 15.99

Earnings vs. Estimates